Qualigen Therapeutics(US:QLGN) Globenewswire·2025-09-30 20:00Core Insights - Univest Securities announced a strategic investment of $41 million in Qualigen Therapeutics, led by Faraday Future with approximately $30 million [1][2][3] - The investment allows Faraday Future to hold approximately 55% of Qualigen's pro forma common stock, with YT Jia, the Founder and Global Co-CEO of Faraday Future, holding approximately 7% [3] Investment Details - The total investment of $41 million includes $30 million from Faraday Future and an additional $4 million from YT Jia, along with contributions from other investors such as SIGN Foundation, Sequoia Capital, IDG, and Circle [2] - The strategic investment was first announced during Faraday Future's annual 919 Futurist Day on September 19, 2025, marking a significant milestone in the execution of FF's "Dual-Flywheel & Dual-Bridge" Eco-Strategy [3] Company Profiles - Qualigen Therapeutics is a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer, with investigational compounds targeting various cancers [6] - Faraday Future is a California-based company aiming to disrupt the automotive industry through a user-centric, technology-first approach, with its flagship model being the FF 91 [5]